Effect and mechanism of norfloxacin removal by guava leaf extract in the ZVI/H2O2 system.

To overcome the bottlenecks of the conventional zero-valent iron Fenton-like (ZVI/H2O2) process, such as low reagent utilization, low applicable pH, and iron sludge contamination, guava leaf extract (GLE) was used as a green promoter to enhance ZVI/H2O2 process in this study. Compared with the ZVI/H2O2 system, the removal rate and kobs of norfloxacin by the ZVI/H2O2/GLE system were increased by 33.76% and 2.19 times, respectively. The experimental investigation of the mechanism showed that the attack of reactive oxygen species was the main pathway for the removal of pollutants, and three types of reactive oxygen species (1O2, O2-,·OH) generations in the ZVI/H2O2/GLE system were effectively promoted by the introduction of GLE. The reactivity improvement was mainly due to the decrease of pH. At the same time, the chelation of iron ions by GLE promoted the Fe(III)/Fe(II) cycle on the catalyst surface was also a minor mechanism to improve the reactivity. This study provides a crucial reference for the practical application of guava leaf to promote the ZVI/H2O2 process in environmental pollution control.

Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study.

AIM: Norfloxacin (NFX) has low ocular bioavailability. The current work aimed to develop NFX-loaded nanoparticle (NP)-laden hydrogels to improve the ocular potential of NFX, minimize the need for frequent instillations and lower undesirable side effects. METHODS: NFX-loaded NPs were developed via the double-emulsion/solvent evaporation technique, according to 21.41 full factorial design, using two types of polylactic-co-glycolic acid (PLGA) polymer and four (drug: polymer) ratios. NPs were evaluated for particle size (PS), polydispersity index (PDI), zeta potential (ZP), drug entrapment efficiency percentage (EE%), drug percentage released after 30 min (Q30min) and 12 hours (Q12h), drug percentage permeated through goat corneas after 30 min (P30min) and 12 hours (P12h) and morphology. Two formulae were statistically selected and incorporated into hydroxypropyl methylcellulose (HPMC)-based hydrogels; G1 - G4. The latter systems were evaluated for appearance, clarity, pH, spreadability, rheology, drug percentages released, drug percentages permeated, antimicrobial activity against Pseudomonas aeruginosa, and histopathological changes. RESULTS: The selected NPs (NP2 and NP6) were spherical in shape and possessed suitable PS (392.02 nm and 190.51 nm) and PDI (0.17 and 0.18), high magnitude of ZP (-30.43 mV and -33.62 mV), high EE% (79.24% and 91.72%), low Q30min (10.96% and 16.65%) and P30min (17.39% and 21.05%) and promising Q12h (58.23% and 71.20%) and P12h (53.31% and 65.01%), respectively. Clear, spreadable, tolerable, pseudoplastic, and thixotropic HPMC-based hydrogels were developed. They showed more prolonged drug release and drug permeation profiles. NP2- and NP6-laden hydrogels (G3 and G4 systems, respectively) had promising antibacterial activity, and reasonable histopathological safety. CONCLUSION: G3 and G4 are potential ocular delivery systems for NFX.

Effect of hydroxyamines derived from lapachol and norlachol against Staphylococcus aureus strains carrying the NorA efflux pump.

Isolated substances and those organically synthesized have stood out over the years for their therapeutic properties, including their antibacterial activity. These compounds may be an alternative to the production of new antibiotics or may have the ability to potentiate the action of preexisting ones. In this context, the objective of this study was to evaluate the in vitro antibacterial and efflux pump inhibitory activity of hydroxyamines derived from lapachol and norlachol, more specifically the compounds 2-(2-Hydroxyethylamino)-3-(3-methyl-2-butenyl)-1,4 dihydro-1,4-naphthalenedione, 2-(2-Hydroxyethylamino)-3-(2-methyl-propenyl)[1,4]naphthoquinone and 2-(3-Hydroxypropylamino)-3-(3-methyl-2-butenyl)-[1,4]naphthoquinone, against Staphylococcus aureus strains carrying the NorA efflux pump mechanism. The substances were synthesized from 2-hydroxy-quinones, lapachol and nor-lapachol, obtaining the corresponding 2-methoxylated derivatives via dimethyl sulfate alkylation in a basic medium, which then reacted chemoselectively with 2-ethanolamine and 3-propanolamine to form the corresponding amino alcohols. All three molecules underwent a virtual structure-based analysis (docking). The antibacterial activity of the substances was measured by determining their Minimum Inhibitory Concentration (MIC) and a microdilution assay was performed to verify efflux pump inhibition using the substances at a sub-inhibitory concentration. The results were subjected to statistical analysis using an analysis of variance (ANOVA) followed by Bonferroni's post hoc test. The substances obtained MIC values ≥1024 µg/mL, however, a significant reduction of their MICs was observed when the substances were associated with norfloxacin and ethidium bromide, with this effect being attributed to efflux pump inhibition. Following a virtual analysis based on its structure (docking), information regarding the affinity of new ligands for the ABC efflux pump were observed, thus contributing to the understanding of their mechanism of molecular interactions and the discovery of functional ligands associated with a reduction in bacterial resistance.

Tuning down the environmental interests of organoclays for emerging pollutants: Pharmaceuticals in presence of electrolytes.

The impact of electrolytes on the adsorption of emerging pollutants: pharmaceuticals onto layered materials: a raw clay mineral and its nonionic and cationic organoclay derivatives was studied. The selected pharmaceuticals: amoxicillin, norfloxacin, sulfamethoxazole, metoprolol, carbamazepine, and trimethoprim show different electric charges: zwitterionic, anionic, cationic and neutral and hydrophobic character (different LogP). Without any salts, the set of complementary data obtained by UV and infrared spectroscopies, X-ray diffraction points out the importance of the electric charge which represents a key parameter in both the spontaneity and feasibility of the adsorption. In contrast, the hydrophobicity of the analytes plays a minor role but determines the magnitude of the adsorbed amount of pharmaceuticals onto organoclays. With a dual hydrophilic and hydrophobic behavior, nonionic organoclay appears to be the most polyvalent material for the removal of the pharmaceuticals. In the presence of electrolytes (NaCl at a concentration of 1 × 10-2 mol L-1), both nonionic and cationic organoclays show a decrease of their efficiencies, whereas the adsorption is particularly enhanced for Na-Mt except for the cationic species (trimethoprim and metoprolol). Thus, in realistic experimental conditions close to those of natural effluents, raw clay mineral appears as the most appropriate sorbent for the studied pharmaceuticals while it raises the question of the usefulness of organoclays in water remediation strategy.

Competitive sorption and desorption behavior for three fluoroquinolone antibiotics in a wastewater treatment wetland soil.

Significant amounts of pharmaceuticals are discharged into the environment through wastewater effluent. Sorption has been shown to be a significant aqueous removal pathway for many of these compounds. Competition between ciprofloxacin (CIP), ofloxacin (OFL) and norfloxacin (NOR) and their sorption to, and desorption from, a surrogate Louisiana wastewater treatment wetland soil were investigated to gain insight into the fate and transport of the pollutants within wastewater treatment wetlands. This study was undertaken in the context of a treatment wetland that continuously receives pharmaceuticals. Therefore it is important to understand the total capacity of this soil to sorb these compounds. Sorption to this treatment wetland soil was found to provide a major and potentially long-term removal pathway for these antibiotics from wastewater. LogK(F) values for all three compounds were between 4.09 and 3.90 for sorption and 4.24 and 4.05 microg(1-1/)(n)(cm(3))(1/)(n)g(-1) for desorption. The compounds were sorbed in amounts ranging from 60% to 90% for high and low loading, respectively. The majority of the compounds were sorbed to the soil within the first 20h, indicating that treatment wetland may not need long retention times (weeks to months) in order to remove these compounds. Sorption K(D) values for competition (20 ppm of each compound for 60 ppm of total fluoroquinolones) ranged from 2300 to 3800 cm(3)g(-1) which is between both the 20 (4300-5800 cm(3)g(-1)) and 60 (1300-3000 cm(3)g(-1)) ppm single compound K(D) values, indicating that there is competition between these three compound for sorption sites. Sorption and desorption data (single component and mixture) collectively provide the following evidence: (1) NOR and, to a lesser extent, CIP outcompete OFL for sorption sites, (2) OFL sorbes to its share of "quality" sorption sites, and (3) competition only occurs for lesser "quality" binding sites.

Sorption of acetaminophen, 17alpha-ethynyl estradiol, nalidixic acid, and norfloxacin to silica, alumina. and a hydrophobic medium.

Two pure minerals and a hydrophobic medium were selected to study sorption of pharmaceuticals. The sorption of four pharmaceuticals, acetaminophen (analgesic), 17alpha-ethynyl estradiol (synthetic hormone), nalidixic acid (antibiotic), and norfloxacin (antibiotic), was evaluated with silica, alumina, and Porapak P (a hydrophobic medium). Alumina and silica were selected to represent positively charged and negatively charged aquifer mineral surfaces at neutral pH, respectively, while Porapak P was selected to represent the hydrophobic organic content of an aquifer medium. At neutral pH, acetaminophen, the least hydrophobic pharmaceutical, showed no significant sorption to any of the media, while 17alpha-ethynyl estradiol, the most hydrophobic pharmaceutical, showed significant sorption to Porapak P. Nalidixic acid, which has a carboxyl functional group that is anionic at neutral pH, showed significant adsorption to the positively charged alumina. Norfloxacin, with both a carboxyl (anionic) and a piperazynyl (cationic) group, can exist in four forms (neutral, cationic, anionic, and zwitterionic) depending on the aqueous pH. Norfloxacin also showed significant adsorption than nalidixic acid. Both nalidixic acid and norfloxacin adsorbed to silica and Porapak P to a much lower extent. The pH dependence of nalidixic acid and norfloxacin adsorption to silica and alumina was also studied by varying the pH between 4 and 11. The maximum adsorption of nalidixic acid to alumina occurred near its pKa (pH approximately 6), where the combination of cationic alumina and anionic nalidixic produced maximum adsorption. The maximum adsorption of norfloxacin to alumina was observed at pH approximately 7, which was the region where the zwitterionic form dominated. This research demonstrates that the adsorption of ionizable pharmaceuticals is strongly dependent on the system pH, the pharmaceutical properties (pKa and hydrophobicity), and the nature of the surface charge (point of zero charge). For pharmaceuticals that are uncharged at environmentally relevant pH values, the main sorption factor is their solubility or hydrophobicity; for charged forms, ion exchange is also an important adsorption mechanism.

Assessment of the antibacterial activity of galangin against 4-quinolone resistant strains of Staphylococcus aureus.

The flavonol galangin is present in numerous plants and is a major constituent of Helichrysum aureonitens, a perennial herb used by South African indigenes to treat infection. In the present study, the antibacterial activity of galangin was assessed against 17 strains of 4-quinolone resistant S. aureus using an agar dilution assay. It was determined that the flavonol had a minimum inhibitory concentration (MIC) of approximately 50 microg/ml against 16 of these strains, including those which exhibited 250- and 500-fold increases in norfloxacin resistance. The remaining one strain, which possessed an amino acid alteration in the GrlB subunit of topoisomerase IV, had increased susceptibility to galangin. Control strains of 4-quinolone sensitive S. aureus were also found to have MICs of 50 microg/ml. The topoisomerase IV enzyme may therefore be implicated in the antibacterial mechanism of action of galangin. Clearly however, there is no cross-resistance between galangin and the 4-quinolones, and the flavonol therefore warrants further investigation as an antibacterial agent.